Table 2

Characteristics and prevalence of patients diagnosed with psoriatic arthritis (PsA)

All specialtiesRheumatologists
n%n%
Population 5 677 1385 677 138
Women 2 854 98550.292 854 98550.29
Men 2 822 15349.712 822 15349.71
PsA
Mean age, years 46.747.4
Any 12 7190.2290340.16
Women 731857.54525758.19
Men 540142.46377741.81
Age groups
0–19 1831.44260.29
20–29 5013.943183.52
30–39 12569.8791610.14
40–49 250519.69183320.29
50–59 316824.91231425.61
60–69 312424.56230325.49
≥70 198215.58132414.66
Systemic Tx*
Any 851966.98630769.81
Non-biologic 843466.31624669.14
Biologic 225017.69175919.47
  • *Systemic Tx: methotrexate, leflunomide, ciclosporin, sulfasalazine, etanercept, infliximab, adalimumab, certolizumab pegol, golimumab and ustekinumab.